Condition : Inflammatory Bowel Disease Intervention : Other: No intervention Sponsors : Janssen Biotech, Inc.; Janssen Biotech, Inc.; Merck Active, not recruiting - verified September 2013

Condition : Arthritis, Rheumatoid Intervention : Drug: ofatumumab Sponsor : GlaxoSmithKline Active, not recruiting - verified August 2011

Condition : Arthritis, Rheumatoid Intervention : Drug: ofatumumab Sponsor : GlaxoSmithKline Active, not recruiting - verified August 2011

Condition : Juvenile Idiopathic Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: Placebo; Drug: Non-steroidal anti-inflammatory drugs (NSAIDs); Drug: methotrexate; Drug: corticos...

Condition : Osteoarthritis Interventions : Device: Reflection Ceramic-Ceramic Total Hip Replacement; Device: Reflection FSO V Total Hip Replacement Sponsor : Smith & Nephew, Inc. Active, not recruitin...

Condition : Osteoarthritis Interventions : Device: Reflection Ceramic-Ceramic Total Hip Replacement; Device: Reflection FSO V Total Hip Replacement Sponsor : Smith & Nephew, Inc. Active, not recruitin...

The purpose of this study is to determine the long-term effectiveness and safety of CP-690,550 for the treatment of rheumatoid arthritis. Subjects are only eligible for this study after they have comp...

The purpose of this study is to determine the long-term effectiveness and safety of CP-690,550 for the treatment of rheumatoid arthritis. Subjects are only eligible for this study after they have comp...

The purpose of this study is to determine the long-term effectiveness and safety of CP-690,550 for the treatment of rheumatoid arthritis. Subjects are only eligible for this study after they have comp...

Condition : Arthritis, Rheumatoid Interventions : Drug: ofatumumab; Drug: Placebo Sponsor : GlaxoSmithKline Active, not recruiting - verified August 2011